InvestorsHub Logo
Followers 10
Posts 705
Boards Moderated 0
Alias Born 07/19/2019

Re: None

Thursday, 04/30/2020 10:36:08 AM

Thursday, April 30, 2020 10:36:08 AM

Post# of 186029
I think all of us can agree here that while the CEO compensation that came to light and net loss were less than thrilling, if you're able to chop down the weeds, you'll be able to see a bright future ahead for VRUS.

Everything in the pipeline is definitely profitable, as was shown on a pro-forma basis. Margins are increasing, our MLB license isn't going away and deals are in place, and the PPE addition should definitely yield some positive results. Along with the fact that there is VERIFIED real product coming from this company.

Once stores are re-opened and these guys get their sh*t together on the management/pay structure side of things, this will be something to behold on the OTC. BLF revenue, though I can't speak to how significant it will be, shows up on Q2, and a lot of the pain in terms of dollars of tweaking the product allegedly was realized in Q1.

Considering the pay structure was JUST changed, I'm expecting similar results for Q2. Probably $7M or $8M in revenues with a similar net loss. BUT, the stacking revenues are going to start being hard to ignore. And if they can start clearing more deals over the next 6 weeks along with getting more MLB product out in stores, could get real interesting for Q3.

While Q1 was disappointing for me in SOME respects, I've seen far, far, far worse financials coming from OTC companies I've followed that have made it to the big boards and have more than held their own. Oh, and those companies are STILL showing less revenues than VRUS, some with no gross profit, and seem to show no growth Y-o-Y. This is going to be a long hold, but lot of potential here.